NCT06505759 Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT
| NCT ID | NCT06505759 |
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | Krishnadevaraya College of Dental Sciences & Hospital |
| Condition | Periodontal Pocket |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 36 participants in total. It began in 2024-07-01 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The current study is a prospective randomised study Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis
Eligibility Criteria
Inclusion Criteria: * Patient with have chronic periodontitis in the age group between 30-50 years. * Patients having ≥20 teeth. -.Patients with radiographic evidence of bone loss in atleast two teeth. * Patients who are systematically healthy. * Patients with localized pockets with probing depth of ≤ 5mm. * Patients who are cooperative and able to attend the hospital for regular follow-up. Exclusion Criteria: * Patients who have received any surgical or nonsurgical therapy during past 6months * Pregnant or lactating females. * Use of systemic antibiotics in the past 6 months. * Patient who are not willing to give a written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06505759 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 50 Years, studying Periodontal Pocket. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06505759 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT06505759 currently recruiting?
Yes, NCT06505759 is actively recruiting participants. Contact the research team at prabhujimlv@gmail.com for enrollment information.
Where is the NCT06505759 trial being conducted?
This trial is being conducted at Bengaluru, India.
Who is sponsoring the NCT06505759 clinical trial?
NCT06505759 is sponsored by Krishnadevaraya College of Dental Sciences & Hospital. The trial plans to enroll 36 participants.